Menu Close

Articles on Alzheimer's disease detection

Displaying all articles

Though this genetic form of Alzheimer’s only affects around 1% of the population, it provides useful information on how the disease progresses. Atthapon Raksthaput/ Shutterstock

Alzheimer’s: blood biomarker may help identify the disease ten years before symptoms start

Although autosomal dominant Alzheimer’s disease is very rare, studying it provides researchers with valuable information on how the disease progresses in general.
Alzheimer’s disease is characterized by progressive memory loss, spatial disorientation and many other cognitive and behavioural disorders that ultimately lead to a state of total dependence. (Shutterstock)

FDA approval of controversial Alzheimer’s drug could delay discovery of more promising treatments

The new drug is based on the idea that a build-up of amyloid in the brain leads to the disease. But that hypothesis has been under scrutiny lately.
Dana Gasby, left, interacts with her mother B. Smith in their East Hampton home on Long Island, New York, on Wednesday, January 9, 2019. B. Smith has Alzheimer’s Disease. Karten Moran for The Washington Post via Getty Images

The importance of blood tests for Alzheimer’s: 2 neuroscientists explain the recent findings

A blood test to detect Alzheimer’s disease in people who have symptoms and even those who don’t has been shown to work. Scientists still need to improve its accuracy rate to almost 100%, however.
Genetic testing is available to people who want to know if they carry a variant of a gene that confers susceptibility for Alzheimer’s. But knowing whether to get tested is hard. Billion Photos/Shutterstock.com

Genetic testing: Should I get tested for Alzheimer’s risk?

Alzheimer’s is not only the third leading cause of death in the U.S. but also the most dreaded diagnosis. Genetic testing can help determine susceptibility, but knowing whether to test isn’t easy.

Top contributors

More